Supplementary Table 15 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia Article Swipe
William M. Yashar
,
Brittany M. Curtiss
,
Daniel J. Coleman
,
Jake VanCampen
,
Garth Kong
,
Jommel Macaraeg
,
Joseph Estabrook
,
Emek Demir
,
Nicola Long
,
Daniel Bottomly
,
Shannon K. McWeeney
,
Jeffrey Tyner
,
Brian Druker
,
Julia E. Maxson
,
Theodore P. Braun
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.27034594.v1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1541-7786.27034594.v1
Log2 Normalized Counts of Differentially Expressed Genes from Primary AML Blast Bulk RNA-seq (24 Hours After Drug Treatment)
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/1541-7786.27034594.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4402798536
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4402798536Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1541-7786.27034594.v1Digital Object Identifier
- Title
-
Supplementary Table 15 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid LeukemiaWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-09-16Full publication date if available
- Authors
-
William M. Yashar, Brittany M. Curtiss, Daniel J. Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K. McWeeney, Jeffrey Tyner, Brian Druker, Julia E. Maxson, Theodore P. BraunList of authors in order
- Landing page
-
https://doi.org/10.1158/1541-7786.27034594.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1541-7786.27034594.v1Direct OA link when available
- Concepts
-
Myeloid leukemia, Dual (grammatical number), Enhancer, Cancer research, Myeloid, Table (database), Leukemia, Computational biology, Biology, Computer science, Immunology, Gene, Genetics, Transcription factor, Database, Art, LiteratureTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4402798536 |
|---|---|
| doi | https://doi.org/10.1158/1541-7786.27034594.v1 |
| ids.doi | https://doi.org/10.1158/1541-7786.27034594.v1 |
| ids.openalex | https://openalex.org/W4402798536 |
| fwci | 0.0 |
| type | supplementary-materials |
| title | Supplementary Table 15 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10309 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.980400025844574 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Acute Myeloid Leukemia Research |
| topics[1].id | https://openalex.org/T11215 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9154000282287598 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Chronic Myeloid Leukemia Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778729363 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7682358026504517 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11688946 |
| concepts[0].display_name | Myeloid leukemia |
| concepts[1].id | https://openalex.org/C2780980858 |
| concepts[1].level | 2 |
| concepts[1].score | 0.75886070728302 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q110022 |
| concepts[1].display_name | Dual (grammatical number) |
| concepts[2].id | https://openalex.org/C111936080 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6595175862312317 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q913367 |
| concepts[2].display_name | Enhancer |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5585000514984131 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2779282312 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5372886657714844 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1956561 |
| concepts[4].display_name | Myeloid |
| concepts[5].id | https://openalex.org/C45235069 |
| concepts[5].level | 2 |
| concepts[5].score | 0.47848957777023315 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q278425 |
| concepts[5].display_name | Table (database) |
| concepts[6].id | https://openalex.org/C2778461978 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4493218660354614 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[6].display_name | Leukemia |
| concepts[7].id | https://openalex.org/C70721500 |
| concepts[7].level | 1 |
| concepts[7].score | 0.32706016302108765 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[7].display_name | Computational biology |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.314700722694397 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C41008148 |
| concepts[9].level | 0 |
| concepts[9].score | 0.2205008864402771 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[9].display_name | Computer science |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.1658974289894104 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.16356495022773743 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C54355233 |
| concepts[12].level | 1 |
| concepts[12].score | 0.14553239941596985 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[12].display_name | Genetics |
| concepts[13].id | https://openalex.org/C86339819 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0899462103843689 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q407384 |
| concepts[13].display_name | Transcription factor |
| concepts[14].id | https://openalex.org/C77088390 |
| concepts[14].level | 1 |
| concepts[14].score | 0.04271611571311951 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q8513 |
| concepts[14].display_name | Database |
| concepts[15].id | https://openalex.org/C142362112 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q735 |
| concepts[15].display_name | Art |
| concepts[16].id | https://openalex.org/C124952713 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q8242 |
| concepts[16].display_name | Literature |
| keywords[0].id | https://openalex.org/keywords/myeloid-leukemia |
| keywords[0].score | 0.7682358026504517 |
| keywords[0].display_name | Myeloid leukemia |
| keywords[1].id | https://openalex.org/keywords/dual |
| keywords[1].score | 0.75886070728302 |
| keywords[1].display_name | Dual (grammatical number) |
| keywords[2].id | https://openalex.org/keywords/enhancer |
| keywords[2].score | 0.6595175862312317 |
| keywords[2].display_name | Enhancer |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.5585000514984131 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/myeloid |
| keywords[4].score | 0.5372886657714844 |
| keywords[4].display_name | Myeloid |
| keywords[5].id | https://openalex.org/keywords/table |
| keywords[5].score | 0.47848957777023315 |
| keywords[5].display_name | Table (database) |
| keywords[6].id | https://openalex.org/keywords/leukemia |
| keywords[6].score | 0.4493218660354614 |
| keywords[6].display_name | Leukemia |
| keywords[7].id | https://openalex.org/keywords/computational-biology |
| keywords[7].score | 0.32706016302108765 |
| keywords[7].display_name | Computational biology |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.314700722694397 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/computer-science |
| keywords[9].score | 0.2205008864402771 |
| keywords[9].display_name | Computer science |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.1658974289894104 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.16356495022773743 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/genetics |
| keywords[12].score | 0.14553239941596985 |
| keywords[12].display_name | Genetics |
| keywords[13].id | https://openalex.org/keywords/transcription-factor |
| keywords[13].score | 0.0899462103843689 |
| keywords[13].display_name | Transcription factor |
| keywords[14].id | https://openalex.org/keywords/database |
| keywords[14].score | 0.04271611571311951 |
| keywords[14].display_name | Database |
| language | en |
| locations[0].id | doi:10.1158/1541-7786.27034594.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1541-7786.27034594.v1 |
| locations[1].id | pmh:oai:figshare.com:article/27034594 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Dataset |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/dataset/Supplementary_Table_15_from_Disruption_of_the_MYC_Super-Enhancer_Complex_by_Dual_Targeting_of_FLT3_and_LSD1_in_Acute_Myeloid_Leukemia/27034594 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5028626481 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8850-9850 |
| authorships[0].author.display_name | William M. Yashar |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | William M. Yashar |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5060581274 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5274-8323 |
| authorships[1].author.display_name | Brittany M. Curtiss |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Brittany M. Curtiss |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5068010590 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3414-3160 |
| authorships[2].author.display_name | Daniel J. Coleman |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Daniel J. Coleman |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5032148008 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1361-0927 |
| authorships[3].author.display_name | Jake VanCampen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jake VanCampen |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5025186197 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5262-5406 |
| authorships[4].author.display_name | Garth Kong |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Garth Kong |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5029691160 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6307-5056 |
| authorships[5].author.display_name | Jommel Macaraeg |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jommel Macaraeg |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5069454150 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1027-3315 |
| authorships[6].author.display_name | Joseph Estabrook |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Joseph Estabrook |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5037803004 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-3663-7113 |
| authorships[7].author.display_name | Emek Demir |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Emek Demir |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5046733014 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-9010-8167 |
| authorships[8].author.display_name | Nicola Long |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Nicola Long |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5061516412 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-7191-0990 |
| authorships[9].author.display_name | Daniel Bottomly |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Daniel Bottomly |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5066373576 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8333-6607 |
| authorships[10].author.display_name | Shannon K. McWeeney |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Shannon K. McWeeney |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5058340446 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2133-0960 |
| authorships[11].author.display_name | Jeffrey Tyner |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jeffrey W. Tyner |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5033023115 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-8331-8206 |
| authorships[12].author.display_name | Brian Druker |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Brian J. Druker |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5073522080 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-3871-7221 |
| authorships[13].author.display_name | Julia E. Maxson |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Julia E. Maxson |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5032381895 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6248-2143 |
| authorships[14].author.display_name | Theodore P. Braun |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Theodore P. Braun |
| authorships[14].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1541-7786.27034594.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table 15 from Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10309 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.980400025844574 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Acute Myeloid Leukemia Research |
| related_works | https://openalex.org/W2113330652, https://openalex.org/W2061914098, https://openalex.org/W4393004084, https://openalex.org/W4309683845, https://openalex.org/W2118646732, https://openalex.org/W4387565139, https://openalex.org/W2990397977, https://openalex.org/W2012639655, https://openalex.org/W2364732766, https://openalex.org/W30746603 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1541-7786.27034594.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1541-7786.27034594.v1 |
| primary_location.id | doi:10.1158/1541-7786.27034594.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1541-7786.27034594.v1 |
| publication_date | 2024-09-16 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.of | 3 |
| abstract_inverted_index.(24 | 13 |
| abstract_inverted_index.AML | 9 |
| abstract_inverted_index.Bulk | 11 |
| abstract_inverted_index.Drug | 16 |
| abstract_inverted_index.from | 7 |
| abstract_inverted_index.After | 15 |
| abstract_inverted_index.Blast | 10 |
| abstract_inverted_index.Genes | 6 |
| abstract_inverted_index.Hours | 14 |
| abstract_inverted_index.Counts | 2 |
| abstract_inverted_index.Primary | 8 |
| abstract_inverted_index.RNA-seq | 12 |
| abstract_inverted_index.Expressed | 5 |
| abstract_inverted_index.Normalized | 1 |
| abstract_inverted_index.<p>Log2 | 0 |
| abstract_inverted_index.Differentially | 4 |
| abstract_inverted_index.Treatment)</p> | 17 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 15 |
| citation_normalized_percentile.value | 0.29384826 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |